Cutaneous tissue angiotensin-converting enzyme may participate in pathologic scar formation in human skin.

BACKGROUND Many studies have shown that up-regulation of angiotensin-converting enzyme (ACE) participates in adverse fibrous remodeling. Although this has become an accepted fact in the cardiovascular field, the relationship between ACE and cutaneous fibrous remodeling, such as keloid or hypertrophic scars, remains unknown. OBJECTIVE We sought to investigate ACE in normal skin, wounded skin, and pathologic scars. METHODS Ten samples undergoing a normal wound-healing process, 14 samples of pathologic scar tissue, and 15 samples of normal skin were used in this study. Cutaneous tissue ACE activities were measured with high-pressure liquid chromatography. Localization of ACE was assessed by immunohistochemistry. RESULTS The ACE activity in pathologic scar tissue was significantly higher than in normal and wounded skin. Immunohistochemical studies demonstrated that myofibroblasts were stained with anti-ACE antibody. LIMITATIONS The study is small. CONCLUSIONS These results suggest that up-regulated ACE may participate in cutaneous pathologic scar formation the same as the cardiovascular system.

[1]  W. Martin,et al.  Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. , 1990, The American review of respiratory disease.

[2]  M. Artuc,et al.  Human skin: source of and target organ for angiotensin II , 2004, Experimental dermatology.

[3]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[4]  N. Kamatani,et al.  Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. , 2004, Arthritis and rheumatism.

[5]  S. Kondo,et al.  Effects of angiotensin II receptor signaling during skin wound healing. , 2004, The American journal of pathology.

[6]  F. Ramires,et al.  Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart , 1998 .

[7]  R. Giorno.  A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. , 1984, Diagnostic immunology.

[8]  M. Miyazaki,et al.  Vascular angiotensin-converting enzyme activity in man and other species. , 1984, Clinical science.

[9]  J. Catravas,et al.  Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma , 1997, British journal of pharmacology.

[10]  Richard A.F. Clark,et al.  The Molecular and Cellular Biology of Wound Repair , 2012, Springer US.

[11]  F. Verrecchia,et al.  Transforming Growth Factor-β Signaling Through the Smad Pathway: Role in Extracellular Matrix Gene Expression and Regulation , 2002 .

[12]  E. G. Erdös,et al.  Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme). , 1971, The Journal of pharmacology and experimental therapeutics.

[13]  H. Yoshiji,et al.  Angiotensin‐II type 1 receptor interaction is a major regulator for liver fibrosis development in rats , 2001, Hepatology.

[14]  G. Laurent,et al.  Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. , 2000, American journal of respiratory and critical care medicine.

[15]  R. Morishita,et al.  The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Kondo,et al.  Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. , 2001, The American journal of pathology.

[17]  A. Hara,et al.  Tissue angiotensin-converting enzyme and lysosomal enzyme levels in skin diseases. , 1982, Archives of dermatology.

[18]  R. Gyurko,et al.  Angiotensin Receptor Stimulation of Transforming Growth Factor-β in Rat Skin and Wound Healing , 1994 .

[19]  K. Weber,et al.  Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. , 1997, Cardiovascular research.

[20]  S. Macdonald,et al.  Angiotensin II stimulates growth and steroidogenesis in zona fasciculata/reticularis cells from bovine adrenal cortex via the AT1 receptor subtype. , 1993, Endocrinology.

[21]  V. Moulin,et al.  Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors , 2004, Journal of cellular physiology.

[22]  A. Desmoulière,et al.  Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.

[23]  M. Miyazaki,et al.  Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. , 1986, Hypertension.

[24]  Y. Sun,et al.  Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. , 2000, Hypertension.

[25]  A. Sastre,et al.  Serum angiotensin-converting enzyme: elevations in diabetes mellitus. , 1980, Annals of internal medicine.

[26]  R. Atkins,et al.  Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II. , 1997, Kidney international. Supplement.

[27]  W A Hsueh,et al.  Angiotensin II, adhesion, and cardiac fibrosis. , 2000, Cardiovascular research.

[28]  K. Kurppa,et al.  Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis. , 1978, Scandinavian journal of respiratory diseases.

[29]  M. Abiko,et al.  Acceleration of dermal tissue repair by angiotensin II , 1997, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[30]  S. Whitebread,et al.  Preliminary biochemical characterization of two angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.